Journal of Biological Chemistry · 2006 · 40 citations · 19 references
Life SciencesCell BiologyPharmacologyApoptosisChemotherapyMolecular Cell BiologyApoptosis In CancerApoptosis PharmacologyApoptosis RegulationBcl-2 Family ProteinsCell DeathIntrinsic Apoptotic PathwayBax OligomerizationBcl-2 Protein LocalizationBcl-2 Protein OligomerizationBcl-2 Protein PhosphorylationBcl-2 Protein StructureConformational ActivationOligomerizationPro-apoptotic Bax Activation
To gain a broader insight into the role of Bcl-2 proteins in apoptosis induced after mitotic arrest, we investigated the subcellular location, oligomeric structure, and protein interactions of Bax, Bcl-2, and Bcl-xL in vinblastine-treated KB-3 cells. Vinblastine induced the translocation of Bax from the cytosol to the mitochondria, which was accompanied by conformational activation and oligomerization of Bax. Bcl-2 was located in the mitochondria, underwent multisite phosphorylation after vinblastine treatment, and was strictly monomeric under all conditions. In contrast, in control cells, Bcl-xL existed in both monomeric (30 kDa) and oligomeric (150 kDa) forms. Treatment with agents that induced Bcl-xL phosphorylation (microtubule inhibitors) caused loss of the 150-kDa form, but this species was unaffected by apoptotic stimuli that did not stimulate phosphorylation. Vinblastine also promoted Bax activation and Bax oligomerization in HCT116 colon cancer cells. Both wild-type and Bax-deficient HCT116 cells expressed the 150-kDa form of Bcl-xL, which was depleted similarly in both cell lines upon vinblastine treatment. Co-immunoprecipitation studies revealed that in untreated KB-3 cells inactive cytosolic Bax interacted with Bcl-xL, whereas in vinblastine-treated cells, activated mitochondrial Bax did not interact with Bcl-xL. Interaction of Bcl-2 with Bax was not observed under any condition. Overexpression of Bcl-xL inhibited vinblastine-induced Bax activation and Bax dimerization and in parallel inhibited apoptosis. The results indicate that vinblastine-induced apoptosis requires translocation, activation, and oligomerization of Bax and is associated with specific changes in the oligomeric properties of Bcl-xL, which occur independently of Bax.
19
Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death
Michael C. Wei, Wei‐Xing Zong, Emily H. Cheng et al. · Science · 2001 · 3.9K citations · Full text
Role of <i>BAX</i> in the Apoptotic Response to Anticancer Agents
Lin Zhang, Jian Yu, Ben Ho Park et al. · Science · 2000 · 860 citations
Medicine, Oncology, Pharmacology +17
Annals of Internal Medicine · 1992 · 793 citations
Medicine, Oncology, Pharmacology +17